These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29530313)

  • 1. Pharmacogenetics and application in pediatrics.
    Neyro V; Jacqz-Aigrain E; Adam de Beaumais T
    Therapie; 2018 Apr; 73(2):157-163. PubMed ID: 29530313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics: Applications to Pediatric Patients.
    Adam de Beaumais T; Jacqz-Aigrain E
    Adv Pharmacol; 2018; 83():191-215. PubMed ID: 29801575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized Medicine in the Paediatric Population: The Balance Between Pharmacogenetic Progress and Bioethics.
    Schiavone S; Neri M; Pomara C; Riezzo I; Trabace L; Turillazzi E
    Curr Pharm Biotechnol; 2017; 18(3):253-262. PubMed ID: 28176639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics for Drug Dosing in Children: Current Use, Knowledge, and Gaps.
    Hoshitsuki K; Fernandez CA; Yang JJ
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1(Suppl 1):S188-S192. PubMed ID: 34185912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundamentals of Pharmacogenetics in Personalized, Precision Medicine.
    Valdes R; Yin DT
    Clin Lab Med; 2016 Sep; 36(3):447-59. PubMed ID: 27514461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics and pharmacoepigenomics in pediatric medicine.
    Shastry BS
    Methods Mol Biol; 2014; 1175():671-85. PubMed ID: 25150880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of drug response in Parkinson's disease.
    Džoljić E; Novaković I; Krajinovic M; Grbatinić I; Kostić V
    Int J Neurosci; 2015; 125(9):635-44. PubMed ID: 25226559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations for Implementing Precision Therapeutics for Children.
    McLaughlin MJ; Wagner J; Shakhnovich V; Carleton B; Leeder JS
    Clin Transl Sci; 2019 Mar; 12(2):140-150. PubMed ID: 30516322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogeny and drug metabolism in newborns.
    Dotta A; Chukhlantseva N
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics in older people: what we know and what we need to know.
    Seripa D; Paroni G; Urbano M; Santini SA; D'Onofrio G; Pilotto A
    J Nephrol; 2012; 25 Suppl 19():S38-47. PubMed ID: 22476963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and Response.
    Kamath A; Srinivasamurthy SK; Chowta MN; Ullal SD; Daali Y; Chakradhara Rao US
    Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics in pediatrics: personalized medicine showing eminent promise.
    Mele C; Goldschmidt K
    J Pediatr Nurs; 2014; 29(4):378-82. PubMed ID: 24880100
    [No Abstract]   [Full Text] [Related]  

  • 13. How personalized medicine became genetic, and racial: Werner Kalow and the formations of pharmacogenetics.
    Jones DS
    J Hist Med Allied Sci; 2013 Jan; 68(1):1-48. PubMed ID: 21908852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.
    Arbitrio M; Di Martino MT; Scionti F; Agapito G; Guzzi PH; Cannataro M; Tassone P; Tagliaferri P
    Oncotarget; 2016 Aug; 7(33):54028-54050. PubMed ID: 27304055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-maturational covariates for dynamic systems pharmacology models in neonates, infants, and children: Filling the gaps beyond developmental pharmacology.
    Allegaert K; Simons SHP; Tibboel D; Krekels EH; Knibbe CA; van den Anker JN
    Eur J Pharm Sci; 2017 Nov; 109S():S27-S31. PubMed ID: 28506866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic steatohepatitis in precision medicine: Unraveling the factors that contribute to individual variability.
    Clarke JD; Cherrington NJ
    Pharmacol Ther; 2015 Jul; 151():99-106. PubMed ID: 25805597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep Pharmacogenetics: The Promise of Precision Medicine.
    Krystal AD; Prather AA
    Sleep Med Clin; 2019 Sep; 14(3):317-331. PubMed ID: 31375201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling.
    Magliocco G; Rodieux F; Desmeules J; Samer CF; Daali Y
    Pediatr Res; 2020 Feb; 87(3):441-449. PubMed ID: 31600772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?
    Olivera GG; Urtasun A; Sendra L; Aliño SF; Yáñez Y; Segura V; Gargallo P; Berlanga P; Castel V; Cañete A; Herrero MJ
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ontogeny and the Application of Pharmacogenomics to Pediatric Drug Development.
    Green D
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S82-S86. PubMed ID: 31502695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.